Long COVID in children and adolescents
GHDx Entry last modified on: Apr 10, 2023
COVID-19
Dataset Records for COVID-19
Displaying 1351 - 1400 of 1561
Seroprevalence of SARS-CoV-2-Specific IgG Antibodies Among Adults Living in Connecticut: Post-Infection Prevalence (PIP) Study
GHDx Entry last modified on: Jan 31, 2024
SARS-CoV-2 Seroprevalence in People Referred to Private Medical Laboratories in Different Districts of Tehran, Iran from May 2020 to April 2021
GHDx Entry last modified on: Mar 14, 2022
Seroprevalence of anti-SARS-CoV-2 antibodies in COVID-19 patients and healthy volunteers up to 6 months post disease onset
GHDx Entry last modified on: Mar 14, 2022
Prevalence and determinants of serum antibodies to SARS-CoV-2 in the general population of the Gardena valley
GHDx Entry last modified on: Jan 31, 2024
Characterizing long COVID in an international cohort: 7 months of symptoms and their impact
GHDx Entry last modified on: Apr 14, 2022
Screening of severe acute respiratory syndrome coronavirus-2 infection during labor and delivery using polymerase chain reaction and immunoglobulin testing
GHDx Entry last modified on: Apr 10, 2023
Maternal mortality associated with COVID-19 in Brazil in 2020 and 2021: Comparison with non-pregnant women and men
GHDx Entry last modified on: Apr 10, 2023
COVID-19 infection in pregnancy: a single center experience with 75 cases
GHDx Entry last modified on: Apr 10, 2023
The association between SARS-CoV-2 infection and preterm delivery: a prospective study with a multivariable analysis
GHDx Entry last modified on: Apr 10, 2023
Universal screening identifies asymptomatic carriers of SARS-CoV-2 among pregnant women in India
GHDx Entry last modified on: Apr 10, 2023
Major impact of COVID-19 national containment on activities in the French northern comprehensive cancer center
GHDx Entry last modified on: Apr 10, 2023
Brazilian Dialysis Survey 2020
GHDx Entry last modified on: Feb 21, 2024
Long-term sequelae are highly prevalent one year after hospitalization for severe COVID-19
GHDx Entry last modified on: Mar 22, 2024
Life stressors significantly impact long-term outcomes and post-acute symptoms 12-months after COVID-19 hospitalization
GHDx Entry last modified on: Mar 22, 2024
Long COVID: rheumatologic/musculoskeletal symptoms in hospitalized COVID-19 survivors at 3 and 6months
GHDx Entry last modified on: Mar 22, 2024
Persistent COVID-19 Symptoms at 6 Months After Onset and the Role of Vaccination Before or After SARS-CoV-2 Infection
GHDx Entry last modified on: Mar 22, 2024
Long-term cognitive and functional status in Danish ICU patients with COVID-19
GHDx Entry last modified on: Mar 22, 2024
COVID-19 pandemic in Germany
Event data:
Epi surveillance
Seroprevalence of anti-SARS-CoV-2 IgG antibodies in Geneva, Switzerland (SEROCoV-POP): a population-based study
GHDx Entry last modified on: Jan 31, 2024
Severe Acute Respiratory Syndrome Coronavirus 2 Antibody Prevalence in Blood in a Large School Community Subject to a Coronavirus Disease 2019 Outbreak: A Cross-sectional Study
GHDx Entry last modified on: Mar 14, 2022
Olfactory and Gustatory Outcomes in COVID-19: A Prospective Evaluation in Nonhospitalized Subjects
GHDx Entry last modified on: Mar 14, 2022
Neurological Manifestations in Critically Ill Patients With COVID-19: A Retrospective Study
GHDx Entry last modified on: Jan 31, 2024
Characteristics and Maternal and Birth Outcomes of Hospitalized Pregnant Women with Laboratory-Confirmed COVID-19 - COVID-NET, 13 States, March 1-August 22, 2020
GHDx Entry last modified on: Mar 14, 2022
Characteristics and outcomes of pregnant women admitted to hospital with confirmed SARS-CoV-2 infection in UK: national population based cohort study
GHDx Entry last modified on: Mar 14, 2022
Anxiety and depression in COVID-19 survivors: Role of inflammatory and clinical predictors
GHDx Entry last modified on: Mar 14, 2022
Obstetric Hemorrhage Risk Associated with Novel COVID-19 Diagnosis from a Single-Institution Cohort in the United States
GHDx Entry last modified on: Jan 31, 2024
Update: Characteristics of Symptomatic Women of Reproductive Age with Laboratory-Confirmed SARS-CoV-2 Infection by Pregnancy Status - United States, January 22-October 3, 2020
GHDx Entry last modified on: Mar 14, 2022
Nationwide seroprevalence of SARS-CoV-2 and identification of risk factors in the general population of the Netherlands during the first epidemic wave
GHDx Entry last modified on: May 12, 2022
Prevalence of SARS-CoV-2 antibodies in France: results from nationwide serological surveillance. Preprint.
GHDx Entry last modified on: May 12, 2022
The Seroprevalence of COVID-19 in Intravenous Drug Users in Comparison to Non-drug Users
GHDx Entry last modified on: Mar 14, 2022
Temporal trends of SARS-CoV-2 seroprevalence in transfusion blood donors during the first wave of the COVID-19 epidemic in Kenya
GHDx Entry last modified on: Mar 14, 2022
Seroprevalence and asymptomatic carrier status of SARS-CoV-2 in Wuhan City and other places of China
GHDx Entry last modified on: Jan 31, 2024
SARS-CoV-2 has been circulating in northeastern Brazil since February 2020: evidence for antibody detection in asymptomatic patients
GHDx Entry last modified on: Mar 14, 2022
Nationwide seroprevalence of antibodies against SARS-CoV-2 in Israel
GHDx Entry last modified on: May 12, 2022
Prevalence of SARS-CoV-2 Among Patients Admitted for Childbirth in Southern Connecticut
GHDx Entry last modified on: Jan 31, 2024
Medium-term impact of COVID-19 on pulmonary function, functional capacity and quality of life
GHDx Entry last modified on: Apr 10, 2023
Post-acute COVID-19 outcomes in children with mild and asymptomatic disease
GHDx Entry last modified on: Apr 10, 2023
SARS-CoV-2 seroprevalence and associated factors in Manaus, Brazil: baseline results from the DETECTCoV-19 cohort study
GHDx Entry last modified on: Jan 31, 2024
Low SARS-CoV-2 seroprevalence in the Austrian capital after an early governmental lockdown
GHDx Entry last modified on: Mar 14, 2022
Patient-Reported Outcome Measures After Hospitalization During the COVID-19 Pandemic: A Survey Among COVID-19 and Non-COVID-19 Patients
GHDx Entry last modified on: Apr 10, 2023
Coronavirus Disease 2019 (COVID-19) Seropositivity and Asymptomatic Rates in Healthcare Workers Are Associated with Job Function and Masking
GHDx Entry last modified on: Jan 31, 2024
Pre-Vaccine Positivity of SARS-CoV-2 Antibodies in Alberta, Canada during the First Two Waves of the COVID-19 Pandemic
GHDx Entry last modified on: Jan 31, 2024
Prevalence of SARS-CoV-2 Antibodies after First 6 Months of COVID-19 Pandemic, Portugal
GHDx Entry last modified on: May 12, 2022
Seroprevalence of anti-SARS-CoV-2 antibodies and risk factors among healthy blood donors in Luanda, Angola
GHDx Entry last modified on: Apr 8, 2022
SARS-CoV-2 seroprevalence in Mongolia: Results from a national population survey
GHDx Entry last modified on: Mar 14, 2022
COVID-19 Pandemic Preparedness - Infection Rate and Infection Fatality Ratio Estimates 2020-2021
GHDx Entry last modified on: Jul 28, 2023
Disease Severity and Perinatal Outcomes of Pregnant Patients With Coronavirus Disease 2019 (COVID-19)
GHDx Entry last modified on: Apr 10, 2023
Analysis of prevalence and sociodemographic conditions among women in labor with and without COVID-19 in public hospitals in Chile
GHDx Entry last modified on: Apr 10, 2023
SARS-CoV-2 Infection among Pregnant and Postpartum Women, Kenya, 2020-2021
GHDx Entry last modified on: Apr 10, 2023
Subscribe